体外受精検査(IVF)の世界市場2021年ー2031年:検査タイプ別(精子異数性検査、遺伝的適合性検査、着床前遺伝子検査、子宮内膜受容性分析、非侵襲的出生前検査、その他)、エンドユーザー別

◆英語タイトル:In Vitro Fertilization Test Market (Test Type: Sperm Aneuploidy Test, Genetic Compatibility Test, Preimplantation Genetic Testing, Endometrial Receptivity Analysis, Noninvasive Prenatal Testing, and Others; and End User: Fertility Clinics, Hospitals, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2031
◆商品コード:TMR21JU022
◆発行会社(リサーチ会社):Transparency Market Research
◆発行日:2021年5月31日
◆ページ数:215
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single User(1名様閲覧)USD5,795 ⇒換算¥637,450見積依頼/購入/質問フォーム
Site Licence(同一拠点内共有可)USD8,795 ⇒換算¥967,450見積依頼/購入/質問フォーム
Enterprise Licence(複数拠点内共有可)USD11,795 ⇒換算¥1,297,450見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はTransparency Market Research社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Transparency Market Research社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

Transparency Market Research社の本調査レポートでは、体外受精検査(IVF)の世界市場を広く調査し、序論、仮定・調査手法、エグゼクティブサマリー、市場概要、キーインサイト、検査タイプ別(精子異数性検査、遺伝的適合性検査、着床前遺伝子検査、子宮内膜受容性分析、非侵襲的出生前検査)分析、エンドユーザー別分析、地域別(北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ)分析、競争状況などの項目を掲載しています。
・序論
・仮定・調査手法
・エグゼクティブサマリー
・市場概要
・キーインサイト
・体外受精検査(IVF)の世界市場規模:検査タイプ別(精子異数性検査、遺伝的適合性検査、着床前遺伝子検査、子宮内膜受容性分析、非侵襲的出生前検査)
・体外受精検査(IVF)の世界市場規模:エンドユーザー別
・体外受精検査(IVF)の世界市場規模:地域別(北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ)
・競争状況
【レポートの概要】

In Vitro Fertilization Test Market – Scope of Report

TMR’s report on the in vitro fertilization test market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market over the forecast period from 2021 to 2031. The report provides the overall revenue of the global in vitro fertilization test market for the period of 2017–2031, considering 2020 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR) of the global in vitro fertilization test market for the forecast period of 2021–2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with industry leaders and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the global in vitro fertilization test market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various phenomena in the global in vitro fertilization test market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the in vitro fertilization test market. These indices serve as valuable tools for existing market players as well as for entities interested in participating in the in vitro fertilization test market.

The report also delves into the competitive landscape of the global in vitro fertilization test market. Key players operating in the global in vitro fertilization test market have been identified and each one of these has been profiled for distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players in the in vitro fertilization test market profiled in this report.

Key Questions Answered in In Vitro Fertilization Test Market Report
How does the development of in vitro fertilization tests provide scope of growth in the global in vitro fertilization test market?
How alliances and partnerships among players are widening the scope of new line of technologies for in vitro fertilization test?
What are the revenue share projections of key segments under various criteria in the in vitro fertilization test market during the forecast period?
Which segment is likely to register highest revenue until the end of the forecast period in 2031?
How is the evolving healthcare system in developing countries in Asia Pacific making an impact on the overall in vitro fertilization test market?

In Vitro Fertilization Test Market – Research Objectives and Research Approach
The comprehensive report on the global in vitro fertilization test market begins with an overview of the market, followed by the scope and objectives of this study. Following this, the report provides detailed explanation of the objectives behind this study and healthcare compliances laid down by accredited agencies in the purview of line of procedure for in vitro fertilization test.

For reading comprehensibility, the report is compiled in a chapter-wise layout, with each section further divided into smaller ones. The entire report comprises an exhaustive collection of graphs and tables that are appropriately interspersed in the entire compilation. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global in vitro fertilization test market in terms of test type, end user, and region. Key segments under each criteria are studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global in vitro fertilization test market.

【レポートの目次】

1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global In Vitro Fertilization Test Market
4. Market Overview
4.1. Introduction
4.1.1. Market Introduction
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global In Vitro Fertilization Test Market Analysis and Forecast, 2017–2031
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Key Mergers & Acquisitions
5.2. COVID-19 Pandemics Impact on Industry (Value Chain and Short / Mid /Long Term Impact)
5.3. Regulatory Scenario by Region/globally
5.4. Top 3 players operating in the market space
5.5. Key product/brand Analysis
6. Global In Vitro Fertilization Test Market Analysis and Forecast, by Test Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Test Type, 2017–2031
6.3.1. Sperm Aneuploidy Test
6.3.2. Genetic Compatibility Test
6.3.3. Preimplantation Genetic Testing
6.3.4. Endometrial Receptivity Analysis
6.3.5. Noninvasive Prenatal Testing
6.3.6. Others
6.4. Market Attractiveness Analysis, by Test Type
7. Global In Vitro Fertilization Test Market Analysis and Forecast, by End-user
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by End-user, 2017–2031
7.3.1. Fertility Clinics
7.3.2. Hospitals
7.3.3. Others
7.4. Market Attractiveness Analysis, by End-user
8. Global In Vitro Fertilization Test Market Analysis and Forecast, by Region
8.1. Key Findings
8.2. Market Value Forecast by Region
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Middle East & Africa
8.3. Market Attractiveness Analysis, by Country/Region
9. North America In Vitro Fertilization Test Market Analysis and Forecast
9.1. Introduction
9.1.1. Key Findings
9.2. Market Value Forecast, by Test Type, 2017–2031
9.2.1. Sperm Aneuploidy Test
9.2.2. Genetic Compatibility Test
9.2.3. Preimplantation Genetic Testing
9.2.4. Endometrial Receptivity Analysis
9.2.5. Noninvasive Prenatal Testing
9.2.6. Others
9.3. Market Value Forecast, by End-user, 2017–2031
9.3.1. Fertility Clinics
9.3.2. Hospitals
9.3.3. Others
9.4. Market Value Forecast, by Country, 2017–2031
9.4.1. U.S.
9.4.2. Canada
9.5. Market Attractiveness Analysis
9.5.1. By Test Type
9.5.2. By End-user
9.5.3. By Country
10. Europe In Vitro Fertilization Test Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Test Type, 2017–2031
10.2.1. Sperm Aneuploidy Test
10.2.2. Genetic Compatibility Test
10.2.3. Preimplantation Genetic Testing
10.2.4. Endometrial Receptivity Analysis
10.2.5. Noninvasive Prenatal Testing
10.2.6. Others
10.3. Market Value Forecast, by End-user, 2017–2031
10.3.1. Fertility Clinics
10.3.2. Hospitals
10.3.3. Others
10.4. Market Value Forecast, by Country/Sub-region, 2017–2031
10.4.1. Germany
10.4.2. U.K.
10.4.3. France
10.4.4. Spain
10.4.5. Italy
10.4.6. Rest of Europe
10.5. Market Attractiveness Analysis
10.5.1. By Test Type
10.5.2. By End-user
10.5.3. By Country/Sub-region
11. Asia Pacific In Vitro Fertilization Test Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Test Type, 2017–2031
11.2.1. Sperm Aneuploidy Test
11.2.2. Genetic Compatibility Test
11.2.3. Preimplantation Genetic Testing
11.2.4. Endometrial Receptivity Analysis
11.2.5. Noninvasive Prenatal Testing
11.2.6. Others
11.3. Market Value Forecast, by End-user, 2017–2031
11.3.1. Fertility Clinics
11.3.2. Hospitals
11.3.3. Others
11.4. Market Value Forecast, by Country/Sub-region, 2017–2031
11.4.1. China
11.4.2. Japan
11.4.3. India
11.4.4. Australia & New Zealand
11.4.5. Rest of Asia Pacific
11.5. Market Attractiveness Analysis
11.5.1. By Test Type
11.5.2. By End-user
11.5.3. By Country/Sub-region
12. Latin America In Vitro Fertilization Test Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Test Type, 2017–2031
12.2.1. Sperm Aneuploidy Test
12.2.2. Genetic Compatibility Test
12.2.3. Preimplantation Genetic Testing
12.2.4. Endometrial Receptivity Analysis
12.2.5. Noninvasive Prenatal Testing
12.2.6. Others
12.3. Market Value Forecast, by End-user, 2017–2031
12.3.1. Fertility Clinics
12.3.2. Hospitals
12.3.3. Others
12.4. Market Value Forecast, by Country/Sub-region, 2017–2031
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Rest of Latin America
12.5. Market Attractiveness Analysis
12.5.1. By Test Type
12.5.2. By End-user
12.5.3. By Country/Sub-region
13. Middle East & Africa In Vitro Fertilization Test Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Test Type, 2017–2031
13.2.1. Sperm Aneuploidy Test
13.2.2. Genetic Compatibility Test
13.2.3. Preimplantation Genetic Testing
13.2.4. Endometrial Receptivity Analysis
13.2.5. Noninvasive Prenatal Testing
13.2.6. Others
13.3. Market Value Forecast, by End-user, 2017–2031
13.3.1. Fertility Clinics
13.3.2. Hospitals
13.3.3. Others
13.4. Market Value Forecast, by Country/Sub-region, 2017–2031
13.4.1. GCC Countries
13.4.2. South Africa
13.4.3. Rest of Middle East & Africa
13.5. Market Attractiveness Analysis
13.5.1. By Test Type
13.5.2. By End-user
13.5.3. By Country/Sub-region
14. Competition Landscape
14.1. Market Player – Competition Matrix (by Tier and Size of companies)
14.2. Market Share Analysis, by Company, 2020
14.3. Company Profiles
14.3.1. CooperSurgical, Inc.
14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.1.2. Growth Strategies
14.3.1.3. SWOT Analysis
14.3.2. Esco Micro Pte Ltd.
14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.2.2. Growth Strategies
14.3.2.3. SWOT Analysis
14.3.3. FUJIFILM Irvine Scientific
14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.3.2. Growth Strategies
14.3.3.3. SWOT Analysis
14.3.4. Hamilton Thorne, Inc.
14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.4.2. Growth Strategies
14.3.4.3. SWOT Analysis
14.3.5. Vitrolife AB
14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.5.2. Growth Strategies
14.3.5.3. SWOT Analysis
14.3.6. IVFtech ApS
14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.6.2. Growth Strategies
14.3.6.3. SWOT Analysis
14.3.7. Nidacon International AB
14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.7.2. Growth Strategies
14.3.7.3. SWOT Analysis
14.3.8. Igenomix
14.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.8.2. Growth Strategies
14.3.8.3. SWOT Analysis
14.3.9. Thermo Fisher Scientific
14.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.9.2. Growth Strategies
14.3.9.3. SWOT Analysis
14.3.10. Cook
14.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.10.2. Growth Strategies
14.3.10.3. SWOT Analysis
14.3.11. Genea Biomedx
14.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.11.2. Growth Strategies
14.3.11.3. SWOT Analysis
14.3.12. FertiPro N.V
14.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.12.2. Growth Strategies
14.3.12.3. SWOT Analysis
14.3.13. Kitazato Corporation
14.3.13.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.13.2. Growth Strategies
14.3.13.3. SWOT Analysis
14.3.14. PerkinElmer, Inc.
14.3.14.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.14.2. Growth Strategies
14.3.14.3. SWOT Analysis
14.3.15. Natera
14.3.15.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.15.2. Growth Strategies
14.3.15.3. SWOT Analysis
14.3.16. Takara Bio, Inc.
14.3.16.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.16.2. Growth Strategies
14.3.16.3. SWOT Analysis
14.3.17. iGLS
14.3.17.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.17.2. Growth Strategies
14.3.17.3. SWOT Analysis
14.3.18. CiceroDx
14.3.18.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.18.2. Growth Strategies
14.3.18.3. SWOT Analysis

List of Tables

Table 01: Global In Vitro Fertilization Test Market Value (US$ Mn) Forecast, by Test Type, 2017–2031

Table 02: Global In Vitro Fertilization Test Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 03: Global In Vitro Fertilization Test Market Value (US$ Mn) Forecast, by Region, 2017–2031

Table 04: North America In Vitro Fertilization Test Market Value (US$ Mn) Forecast, by Country, 2017–2031

Table 05: North America In Vitro Fertilization Test Market Value (US$ Mn) Forecast, by Test Type, 2017–2031

Table 06: North America In Vitro Fertilization Test Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 07: Europe In Vitro Fertilization Test Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 08: Europe In Vitro Fertilization Test Market Value (US$ Mn) Forecast, by Test Type, 2017–2031

Table 09: Europe In Vitro Fertilization Test Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 10: Asia Pacific In Vitro Fertilization Test Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 11: Asia Pacific In Vitro Fertilization Test Market Value (US$ Mn) Forecast, by Test Type, 2017–2031

Table 12: Asia Pacific In Vitro Fertilization Test Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 13: Latin America In Vitro Fertilization Test Market Value (US$ Mn) Forecast, by Country/Sub-Region, 2017–2031

Table 14: Latin America In Vitro Fertilization Test Market Value (US$ Mn) Forecast, by Test Type, 2017–2031

Table 15: Latin America In Vitro Fertilization Test Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 16: Middle East & Africa In Vitro Fertilization Test Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 17: Middle East & Africa In Vitro Fertilization Test Market Value (US$ Mn) Forecast, by Test Type, 2017–2031

Table 18: Middle East & Africa In Vitro Fertilization Test Market Value (US$ Mn) Forecast, by End-user, 2017–2031

List of Figures

Figure 01: Global In-vitro Fertilization Test Market Value (US$ Mn) Forecast, 2017–2031

Figure 02: Global In-vitro Fertilization Test Market Value Share, by Test Type, 2020

Figure 03: Global In-vitro Fertilization Test Market Value Share, by End-user, 2020

Figure 04: Global In-vitro Fertilization Test Market Value Share, by Region, 2020

Figure 05: Global In Vitro Fertilization Test Market Value Share Analysis, by Test Type, 2020 and 2031

Figure 06: Global In Vitro Fertilization Test Market Attractiveness Analysis, by Test Type, 2021–2031

Figure 07: Global In Vitro Fertilization Test Market Value (US$ Mn), by Sperm Aneuploidy Test, 2017–2031

Figure 08: Global In Vitro Fertilization Test Market Value (US$ Mn), by Genetic Compatibility Test, 2017–2031

Figure 09: Global In Vitro Fertilization Test Market Value (US$ Mn), by Preimplantation Genetic Testing, 2017–2031

Figure 10: Global In Vitro Fertilization Test Market Value (US$ Mn), by Endometrial Receptivity Analysis, 2017–2031

Figure 11: Global In Vitro Fertilization Test Market Value (US$ Mn), by Noninvasive Prenatal Testing, 2017–2031

Figure 12: Global In Vitro Fertilization Test Market Value (US$ Mn), by Others, 2017–2031

Figure 13: Global In Vitro Fertilization Test Market Value Share Analysis, by End-user, 2020 and 2031

Figure 14: Global In Vitro Fertilization Test Market Attractiveness Analysis, by End-user, 2021–2031

Figure 15: Global In Vitro Fertilization Test Market Value (US$ Mn), by Fertility Clinics, 2017–2031

Figure 16: Global In Vitro Fertilization Test Market Value (US$ Mn), by Hospitals, 2017–2031

Figure 17: Global In Vitro Fertilization Test Market Value (US$ Mn), by Others, 2017–2031

Figure 18: Global In Vitro Fertilization Test Market Value Share Analysis, by Region, 2020 and 2031

Figure 19: Global In Vitro Fertilization Test Market Attractiveness Analysis, by Region, 2021–2031

Figure 20: North America In Vitro Fertilization Test Market Value (US$ Mn) Forecast, 2017–2031

Figure 21: North America In Vitro Fertilization Test Market Value Share Analysis, by Country, 2020 and 2031

Figure 22: North America In Vitro Fertilization Test Market Attractiveness Analysis, by Country, 2021–2031

Figure 23: North America In Vitro Fertilization Test Market Value Share Analysis, by Test Type, 2020 and 2031

Figure 24: North America In Vitro Fertilization Test Market Attractiveness Analysis, by Test Type, 2021–2031

Figure 25: North America In Vitro Fertilization Test Market Value Share Analysis, by End-user, 2020 and 2031

Figure 26: North America In Vitro Fertilization Test Market Attractiveness Analysis, by End-user, 2021–2031

Figure 27: Europe In Vitro Fertilization Test Market Value (US$ Mn) Forecast, 2017–2031

Figure 28: Europe In Vitro Fertilization Test Market Value Share Analysis, by Country/Sub-region, 2020 and 2031

Figure 29: Europe In Vitro Fertilization Test Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

Figure 30: Europe In Vitro Fertilization Test Market Value Share Analysis, by Test Type, 2020 and 2031

Figure 31: Europe In Vitro Fertilization Test Market Attractiveness Analysis, by Test Type, 2021–2031

Figure 32: Europe In Vitro Fertilization Test Market Value Share Analysis, by End-user, 2020 and 2031

Figure 33: Europe In Vitro Fertilization Test Market Attractiveness Analysis, by End-user, 2021–2031

Figure 34: Asia Pacific In Vitro Fertilization Test Market Value (US$ Mn) Forecast, 2017–2031

Figure 35: Asia Pacific In Vitro Fertilization Test Market Value Share Analysis, by Country/Sub-region, 2020 and 2031

Figure 36: Asia Pacific In Vitro Fertilization Test Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

Figure 37: Asia Pacific In Vitro Fertilization Test Market Value Share Analysis, by Test Type, 2020 and 2031

Figure 38: Asia Pacific In Vitro Fertilization Test Market Attractiveness Analysis, by Test Type, 2021–2031

Figure 39: Asia Pacific In Vitro Fertilization Test Market Value Share Analysis, by End-user, 2020 and 2031

Figure 40: Asia Pacific In Vitro Fertilization Test Market Attractiveness Analysis, by End-user, 2021–2031

Figure 41: Latin America In Vitro Fertilization Test Market Value (US$ Mn) Forecast, 2017–2031

Figure 42: Latin America In Vitro Fertilization Test Market Value Share Analysis, by Country/Sub-region, 2020 and 2031

Figure 43: Latin America In Vitro Fertilization Test Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

Figure 44: Latin America In Vitro Fertilization Test Market Value Share Analysis, by Test Type, 2020 and 2031

Figure 45: Latin America In Vitro Fertilization Test Market Attractiveness Analysis, by Test Type, 2021–2031

Figure 46: Latin America In Vitro Fertilization Test Market Value Share Analysis, by End-user, 2020 and 2031

Figure 47: Latin America In Vitro Fertilization Test Market Attractiveness Analysis, by End-user, 2021–2031

Figure 48: Middle East & Africa In Vitro Fertilization Test Market Value (US$ Mn) Forecast, 2017–2031

Figure 49: Middle East & Africa In Vitro Fertilization Test Market Value Share Analysis, by Country/Sub-region, 2020 and 2031

Figure 50: Middle East & Africa In Vitro Fertilization Test Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

Figure 51: Middle East & Africa In Vitro Fertilization Test Market Value Share Analysis, by Test Type, 2020 and 2031

Figure 52: Middle East & Africa In Vitro Fertilization Test Market Attractiveness Analysis, by Test Type, 2021–2031

Figure 53: Middle East & Africa In Vitro Fertilization Test Market Value Share Analysis, by End-user, 2020 and 2031

Figure 54: Middle East & Africa In Vitro Fertilization Test Market Attractiveness Analysis, by End-user, 2021–2031

Figure 55: Global In Vitro Fertilization Test Market: Company Share Analysis, 2020

Figure 56: CooperSurgical, Inc. Revenue (US$ Mn) and Y-o-Y Growth (%), 2017–2020

Figure 57: CooperSurgical, Inc. Breakdown of Net Sales (%), by Region/Country, 2020

Figure 58: CooperSurgical, Inc. Breakdown of Net Sales (%), by Business Segment, 2020

Figure 59: CooperSurgical, Inc. R&D Expenses (US$ Mn) Y-o-Y Growth (%), 2017–2020

Figure 60: FUJIFILM Holding Corporation Revenue (US$ Mn) and Y-o-Y Growth (%), 2018–2020

Figure 61: FUJIFILM Holding Corporation Revenue Breakdown of Net Sales (%), by Business Segment, 2020

Figure 62: FUJIFILM Holding Corporation R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2017–2020

Figure 63: Hamilton Thorne, Inc. Revenue (US$ Mn) and Y-o-Y Growth (%), 2018–2020

Figure 64: Hamilton Thorne, Inc. Breakdown of Net Sales (%), by Business Segment, 2020

Figure 65: Hamilton Thorne, Inc. R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2018–2020

Figure 66: Vitrolife AB Revenue (US$ Mn) and Y-o-Y Growth (%), 2017–2020

Figure 67: Vitrolife AB Breakdown of Net Sales (%), by Region/Country, 2020

Figure 68: Vitrolife AB Breakdown of Net Sales (%), by Business Segment, 2020

Figure 69: Thermo Fisher Scientific Revenue (US$ Mn) and Y-o-Y Growth (%), 2017–2020

Figure 70: Thermo Fisher Scientific Breakdown of Net Sales (%), by Region/Country, 2020

Figure 71: Thermo Fisher Scientific Breakdown of Net Sales (%), by Business Segment, 2020

Figure 72: Thermo Fisher Scientific R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2017–2020

Figure 73: PerkinElmer, Inc. Revenue (US$ Mn) and Y-o-Y Growth (%), 2017–2020

Figure 74: PerkinElmer, Inc. Breakdown of Net Sales (%), by Region/Country, 2020

Figure 75: PerkinElmer, Inc. Breakdown of Net Sales (%), by Business Segment, 2020

Figure 76: PerkinElmer, Inc. R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2018–2020

Figure 77: Natera Revenue (US$ Mn) and Y-o-Y Growth (%), 2017–2020

Figure 78: Natera Breakdown of Net Sales (%), by Region/Country, 2020

Figure 79: Natera R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2018–2020

Figure 80: Takara Bio, Inc. Revenue (US$ Mn) and Y-o-Y Growth (%), 2017–2020

Figure 81: Takara Bio, Inc. Breakdown of Net Sales (%), by Region/Country, 2020

Figure 82: Takara Bio, Inc. Breakdown of Net Sales (%), by Business Segment, 2020

Figure 83: Takara Bio, Inc. R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2018–2020

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[体外受精検査(IVF)の世界市場2021年ー2031年:検査タイプ別(精子異数性検査、遺伝的適合性検査、着床前遺伝子検査、子宮内膜受容性分析、非侵襲的出生前検査、その他)、エンドユーザー別]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆